Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit-Reference-Cited by-同舟云学术

Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit

Published:2022-08-10 Issue: Volume:2022 Page:1-4
ISSN:1687-9635
Container-title:Case Reports in Medicine
language:en
Short-container-title:Case Reports in Medicine

Author:

Mohaghegh Fatemeh¹^ORCID,Hatami Parvaneh²^ORCID,Aryanian Zeinab²³^ORCID,Fatemi Farahnaz¹^ORCID,Mohseni Afshar Zeinab⁴^ORCID

Affiliation:

1. Department of Dermatology, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Dermatology, Babol University of Medical Sciences, Babol, Iran

4. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Abstract

Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://downloads.hindawi.com/journals/crim/2022/9880827.pdf

Reference31 articles.

1. Cutaneous manifestations in COVID-19: lessons learned from current evidence;P. Suchonwanit;Journal of the American Academy of Dermatology,2020

2. Dermatological manifestations associated with COVID‐19: a comprehensive review of the current knowledge;Z. Mohseni Afshar;Journal of Medical Virology,2021

3. Palmar erythema as the sole manifestation of COVID-19;B. Panambur;Cureus,2020

4. Cutaneous manifestations in COVID-19: report on 31 cases from five countries;C. Rodriguez-Cerdeira;Biology,2021

5. Pustular psoriasis flare-up in a patient with COVID‐19;R. Miladi;Journal of Cosmetic Dermatology,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute generalised exanthematous pustulosis and herpes simplex virus: a case of possible overlap;BMJ Case Reports;2024-08

2. COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID‐19?;Journal of Cosmetic Dermatology;2023-08-12

3. A case of acute generalized exanthematous pustulosis following COVID‐19 infection and remdesivir;Clinical Case Reports;2023-05-29

4. Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management;American Journal of Clinical Dermatology;2023-05-08

5. Various aspects of the relationship between vitiligo and the COVID‐19 pandemic or SARS‐CoV‐2 vaccines: Clinical pearls for dermatologists;Journal of Cosmetic Dermatology;2023-02-09